SBI Life Insurance Declares Interim Dividend for FY26
SBI Life Insurance has announced an interim dividend of ₹2.70 per equity share for the financial year 2025 to 26. Shareholders whose names appear on the record date of March 6, 2026 will be eligible to receive the payout.The company stated...
360 one mutual fund
aditya infotech
axis mutual fund
emmvee photovoltaic power ltd
hdfc life insurance
indian railway finance corporation ltd
kfin technologies ltd
kotak mahindra mutual fund
lupin
motilal oswal mutual fund
reliance industries ltd
sanofi india ltd
sbi life insurance
shaily engineering plastics
tata capital ltd
zydus lifesciences
Lupin Receives USFDA Nod for Seizure Treatment Drug
Mumbai based pharmaceutical major Lupin Ltd on Wednesday announced that it has received approval from the U.S. Food and Drug Administration to market a generic medication used in the treatment of seizures in the United States.The approval...
anda
brivaracetam
briviact
bse
drug approval
generic medication
india
lupin
oral solution
pharmaceutical industry
pharmaceutical sales
seizures
us market
usfda
New Delhi, February 23Drug maker Lupin on Monday announced that it has received approval from the European Commission for its biosimilar Ranluspec, used in the treatment of several serious eye conditions.The approval follows a recent positive opinion from the Committee for Medicinal Products...